دورية أكاديمية
Cost‐effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab‐paclitaxel in borderline resectable/locally advanced pancreatic cancer patients.
| العنوان: | Cost‐effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab‐paclitaxel in borderline resectable/locally advanced pancreatic cancer patients. |
|---|---|
| المؤلفون: | Ingram, Myles A., Lauren, Brianna N., Pumpalova, Yoanna, Park, Jiheum, Lim, Francesca, Bates, Susan E., Kastrinos, Fay, Manji, Gulam A., Kong, Chung Yin, Hur, Chin |
| المصدر: | Cancer Reports; Sep2022, Vol. 5 Issue 9, p1-8, 8p |
| قاعدة البيانات: | Complementary Index |
Full Text Finder | تدمد: | 25738348 |
|---|---|
| DOI: | 10.1002/cnr2.1565 |